Pharmacokinetics of Apixaban in Peritoneal Dialysis | MicrobiomeTrials← Back to trialsNCT05532878
Pharmacokinetics of Apixaban in Peritoneal Dialysis
CompletedOBSERVATIONAL
Trial Details
Start: 2020-12-01Est. Completion: 2025-12-31
Enrollment target: 50 participants Locations- Department of Medicine & Therapeutics, Prince of Wales Hospital, Shatin, Hong Kong
Other microbiome trials you might be interested in
Cardiovascular DiseasesArrhythmias, CardiacAtrial Fibrillation
The ICE-ACCESS study is a prospective observational study designed to evaluate how procurement reliability, distribution…
New York, United StatesCompleted Aug 31, 2027
Persistent Atrial Fibrillation
The goal of this clinical study is to find out which treatment works best for people with persistent atrial fibrillation…
Bruges, BelgiumEst. completion Jan 2027
Recruiting
Atrial Fibrillation (AF)Pulmonary Embolism (PE)Left Atrial Appendage Thrombosis
This study aims to investigate whether a quick, additional CT scan of the heart, performed immediately after a standard …
Manhasset, United StatesEst. completion Apr 2027